{
    "clinical_study": {
        "@rank": "137907", 
        "arm_group": [
            {
                "arm_group_label": "Ritalin", 
                "arm_group_type": "Active Comparator", 
                "description": "Ritalin treatment at different doses"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Two meetings, one of which will be given a placebo and the other will be given a low dose of Ritalin, randomly."
            }
        ], 
        "brief_summary": {
            "textblock": "In this study we try to identify the signature of brain activity in the EEG of attention\n      deficit disorder (ADHD) patients compared to healthy subjects under different doses of\n      Ritalin (methylphenidate) treatment."
        }, 
        "brief_title": "Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "\"Attention Deficit Hyperactivity Disorder\"", 
        "condition_browse": {
            "mesh_term": [
                "Attention Deficit Disorder with Hyperactivity", 
                "Hyperkinesis"
            ]
        }, 
        "detailed_description": {
            "textblock": "In this study we try to identify the signature of brain activity in the EEG of attention\n      deficit disorder (ADHD) patients compared to healthy subjects under different doses of\n      Ritalin (methylphenidate) treatment. All subjects will undergo 1-4 EEG sessions. In each\n      session we will use a different dose of Ritalin or placebo. A detailed neuropsychological\n      tests will be done during the EEG recording. A powerful machine-learning techniques will be\n      used in order to find a specific signature of ADHD and Ritalin treatment in the EEG\n      recording."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy subjects, aged 18-50 years.\n\n          -  Subjects aged 18-50 years diagnosed with ADHD and treated with Ritalin regularly (at\n             least once a week).\n\n        Exclusion Criteria:\n\n          -  Patients previously diagnosed as suffering from a brain disease except for ADHD.\n\n          -  Patients after traumatic head injury.\n\n          -  Patients who are unable to express their consent to participate in the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01962181", 
            "org_study_id": "RE0379-HMO-STILL"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ritalin", 
                "description": "Patients with ADHD and healthy subjects will be examined under Ritalin or placebo", 
                "intervention_name": "Ritalin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Methylphenidate"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "EEG Attention Deficit / Hyperactivity Disorder (ADHD) Ritalin machine learning", 
        "lastchanged_date": "October 10, 2013", 
        "location": {
            "contact": {
                "email": "renanaeitan@gmail.com", 
                "last_name": "Renana Eitan, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Jerusalem", 
                    "country": "Israel", 
                    "zip": "91000"
                }, 
                "name": "Hadassah Medical Center"
            }, 
            "investigator": {
                "last_name": "Renana Eitan, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Identifying Characteristic Signature of Brain Activity of Electroencephalogram Records in Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment", 
        "overall_contact": {
            "email": "renanaeitan@gmail.com", 
            "last_name": "Renana Eitan, MD"
        }, 
        "overall_contact_backup": {
            "last_name": "Shahar Arzy, MD"
        }, 
        "overall_official": {
            "affiliation": "Hadassah Medical Center", 
            "last_name": "Renana Eitan, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome measure is the difference in the analysis of EEG recording (for example, resting oscillation activity and Event-related-Potentials) in Attention Deficit / Hyperactivity Disorder (ADHD) vs. healthy subjects.", 
            "measure": "Resting oscillation activity and Event-related-Potentials in Attention Deficit / Hyperactivity Disorder (ADHD) and healthy subjects.", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01962181"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Hadassah Medical Organization", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hadassah Medical Organization", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}